BOMEDYS: what changed
What changed
BOMEDYS
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€325,199
2024 · €547,777-€222,578
Equity
€4.0m
2024 · €3.9m+€134,027
Cash
€548,314
2024 · €409,174+€139,140
Balance sheet total
€7.3m
2024 · €8.2m-€840,740
Largest movements
Assets
- Receivables within one year -€804,334
down €804,334 (-26.3%), from €3.1m to €2.2m
of which Trade receivables: -€787,916
- Intangible fixed assets -€165,641
down €165,641 (-25.3%), from €654,568 to €488,927
- Stocks and contracts -€152,953
down €152,953 (-4.6%), from €3.3m to €3.2m
- Cash +€139,140
up €139,140 (+34.0%), from €409,174 to €548,314
mainly Receivables within one year (+€804,334) and Net result for the year (+€325,199)
- Current investments +€100,000
up €100,000 (+50.0%), from €200,000 to €300,000
Equity and liabilities
- Trade debts -€847,446
down €847,446 (-35.5%), from €2.4m to €1.5m
- Reserves +€134,027
up €134,027 (+3.6%), from €3.7m to €3.9m
of which Distributable reserves: +€134,027
- Other debts -€108,878
down €108,878 (-36.3%), from €300,192 to €191,314
Income statement
- Goods and materials -€675,558
down €675,558 (-4.6%), from €14.6m to €13.9m
of which Purchases: -€1.1m
- Turnover -€598,613
down €598,613 (-3.1%), from €19.2m to €18.6m
- Services and other goods +€317,127
up €317,127 (+10.5%), from €3.0m to €3.3m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€547,777
Turnover
-€598,613
Other operating income
-€8,002
Goods and materials
+€675,558
Services and other goods
-€317,127
Staff costs
-€126,638
Depreciation
-€38,515
Write-downs
+€81,905
Provisions
+€71,750
Other operating charges
+€3,908
Other operating items
-€4,064
Financial income
-€10,083
Financial charges
+€16,043
Taxes
+€31,301
Result 2025
€325,199
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€623,483
Investment
-€245,147
Financing
-€239,196
Cash 2024
€409,174
From operations (derived)
+€623,483
Net result for the year
+€325,199
Depreciation
+€294,654
Stocks and contracts
+€152,953
Receivables within one year
+€804,334
Deferred charges and accrued income
-€26,914
Provisions
-€10,445
Trade debts
-€847,446
Tax, wage and social debts
+€61,713
Advances received
-€910
Other debts
-€108,878
Accrued charges and deferred income
-€20,776
Investment (derived)
-€245,147
Investment in fixed assets (net)
-€145,147
Current investments
-€100,000
Financing
-€239,196
Debts after one year
-€49,577
Current portion of long-term debt
+€1,552
Contributions, distributions and other
-€191,172
Cash 2025
€548,314
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €8,176,690 | €7,335,950 | -€840,740 | -10.3% |
| Fixed assets | 21/28 | €1,140,319 | €990,811 | -€149,508 | -13.1% |
| Intangible fixed assets | 21 | €654,568 | €488,927 | -€165,641 | -25.3% |
| Tangible fixed assets | 22/27 | €469,128 | €485,261 | +€16,133 | +3.4% |
| Land and buildings | 22 | €221,882 | €215,514 | -€6,368 | -2.9% |
| Plant, machinery and equipment | 23 | €127,598 | €140,894 | +€13,296 | +10.4% |
| Furniture and vehicles | 24 | €107,558 | €122,163 | +€14,604 | +13.6% |
| Other tangible fixed assets | 26 | €12,090 | €6,691 | -€5,399 | -44.7% |
| Financial fixed assets | 28 | €16,622 | €16,622 | = | 0.0% |
| Other financial fixed assets | 284/8 | €16,622 | €16,622 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €16,622 | €16,622 | = | 0.0% |
| Current assets | 29/58 | €7,036,371 | €6,345,138 | -€691,233 | -9.8% |
| Stocks and contracts in progress | 3 | €3,345,652 | €3,192,699 | -€152,953 | -4.6% |
| Stocks | 30/36 | €3,345,652 | €3,192,699 | -€152,953 | -4.6% |
| Goods purchased for resale | 34 | €3,345,652 | €3,192,699 | -€152,953 | -4.6% |
| Amounts receivable within one year | 40/41 | €3,053,708 | €2,249,374 | -€804,334 | -26.3% |
| Trade receivables | 40 | €3,035,809 | €2,247,893 | -€787,916 | -26.0% |
| Other amounts receivable | 41 | €17,899 | €1,481 | -€16,418 | -91.7% |
| Current investments | 50/53 | €200,000 | €300,000 | +€100,000 | +50.0% |
| Other investments | 51/53 | €200,000 | €300,000 | +€100,000 | +50.0% |
| Cash at bank and in hand | 54/58 | €409,174 | €548,314 | +€139,140 | +34.0% |
| Deferred charges and accrued income | 490/1 | €27,838 | €54,752 | +€26,914 | +96.7% |
| Total equity and liabilities | 10/49 | €8,176,690 | €7,335,950 | -€840,740 | -10.3% |
| Equity | 10/15 | €3,863,379 | €3,997,406 | +€134,027 | +3.5% |
| Contributions | 10/11 | €136,341 | €136,341 | = | 0.0% |
| Capital | 10 | €136,341 | €136,341 | = | 0.0% |
| Issued capital | 100 | €136,341 | €136,341 | = | 0.0% |
| Reserves | 13 | €3,727,038 | €3,861,065 | +€134,027 | +3.6% |
| Non-distributable reserves | 130/1 | €15,323 | €15,323 | = | 0.0% |
| Legal reserve | 130 | €15,323 | €15,323 | = | 0.0% |
| Tax-exempt reserves | 132 | €145,050 | €145,050 | = | 0.0% |
| Distributable reserves | 133 | €3,566,665 | €3,700,692 | +€134,027 | +3.8% |
| Provisions and deferred taxes | 16 | €61,306 | €50,861 | -€10,445 | -17.0% |
| Provisions for liabilities and charges | 160/5 | €61,306 | €50,861 | -€10,445 | -17.0% |
| Other liabilities and charges | 164/5 | €61,306 | €50,861 | -€10,445 | -17.0% |
| Amounts payable | 17/49 | €4,252,005 | €3,287,683 | -€964,323 | -22.7% |
| Amounts payable after more than one year | 17 | €140,220 | €90,644 | -€49,577 | -35.4% |
| Financial debts | 170/4 | €140,220 | €90,644 | -€49,577 | -35.4% |
| Credit institutions | 173 | €140,220 | €90,644 | -€49,577 | -35.4% |
| Amounts payable within one year | 42/48 | €4,089,985 | €3,196,015 | -€893,970 | -21.9% |
| Current portion of amounts payable after more than one year | 42 | €48,024 | €49,577 | +€1,552 | +3.2% |
| Trade debts | 44 | €2,388,519 | €1,541,073 | -€847,446 | -35.5% |
| Suppliers | 440/4 | €2,388,519 | €1,541,073 | -€847,446 | -35.5% |
| Advances received on contracts in progress | 46 | €1,001,833 | €1,000,923 | -€910 | -0.1% |
| Taxes, remuneration and social security | 45 | €351,416 | €413,129 | +€61,713 | +17.6% |
| Taxes | 450/3 | €162,763 | €231,197 | +€68,434 | +42.0% |
| Remuneration and social security | 454/9 | €188,653 | €181,932 | -€6,721 | -3.6% |
| Other amounts payable | 47/48 | €300,192 | €191,314 | -€108,878 | -36.3% |
| Accrued charges and deferred income | 492/3 | €21,799 | €1,024 | -€20,776 | -95.3% |
| Operating income | 70/76A | €20,177,295 | €19,567,622 | -€609,673 | -3.0% |
| Turnover | 70 | €19,169,455 | €18,570,841 | -€598,613 | -3.1% |
| Other operating income | 74 | €1,004,782 | €996,780 | -€8,002 | -0.8% |
| Non-recurring operating income | 76A | €3,058 | €0 | -€3,058 | -100% |
| Operating charges | 60/66A | €19,394,250 | €19,044,416 | -€349,835 | -1.8% |
| Goods for resale, raw materials and consumables | 60 | €14,551,908 | €13,876,350 | -€675,558 | -4.6% |
| Purchases | 600/8 | €14,788,622 | €13,703,061 | -€1.1m | -7.3% |
| Change in stocks: decrease (increase) | 609 | -€236,714 | €173,289 | +€410,003 | |
| Services and other goods | 61 | €3,017,698 | €3,334,826 | +€317,127 | +10.5% |
| Remuneration, social security and pensions | 62 | €1,419,850 | €1,546,488 | +€126,638 | +8.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €256,139 | €294,654 | +€38,515 | +15.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €64,753 | -€17,153 | -€81,905 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €61,306 | -€10,445 | -€71,750 | |
| Other operating charges | 640/8 | €22,597 | €18,689 | -€3,908 | -17.3% |
| Non-recurring operating charges | 66A | €0 | €1,006 | +€1,006 | |
| Operating profit (loss) | 9901 | €783,044 | €523,206 | -€259,838 | -33.2% |
| Financial income | 75/76B | €34,549 | €24,466 | -€10,083 | -29.2% |
| Recurring financial income | 75 | €34,549 | €24,466 | -€10,083 | -29.2% |
| Income from current assets | 751 | €5,054 | €2,489 | -€2,564 | -50.7% |
| Other financial income | 752/9 | €29,496 | €21,977 | -€7,519 | -25.5% |
| Financial charges | 65/66B | €87,121 | €71,078 | -€16,043 | -18.4% |
| Recurring financial charges | 65 | €87,121 | €71,078 | -€16,043 | -18.4% |
| Debt charges | 650 | €25,894 | €16,951 | -€8,943 | -34.5% |
| Other financial charges | 652/9 | €61,227 | €54,127 | -€7,100 | -11.6% |
| Profit (loss) for the period before taxes | 9903 | €730,472 | €476,594 | -€253,878 | -34.8% |
| Income taxes | 67/77 | €182,695 | €151,395 | -€31,301 | -17.1% |
| Taxes | 670/3 | €182,695 | €151,395 | -€31,301 | -17.1% |
| Profit (loss) for the period | 9904 | €547,777 | €325,199 | -€222,578 | -40.6% |
| Transfer from tax-exempt reserves | 789 | €168,400 | €0 | -€168,400 | -100% |
| Profit (loss) for the period to be appropriated | 9905 | €716,177 | €325,199 | -€390,978 | -54.6% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.